Anthera Pharmaceuticals, Inc. ANTH
At closeNov 3, 2026, 4:00 PM EST
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 2.62K
- Shares out
- 26.18M
- Forward P/E
- -0.04
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 23.89K
- Avg volume
- 1.20K
- Open
- 0.0001
- Previous close
- 0.0001
- Day's range
- 0.0001 – 0.0001
- Beta
- 2.27
- Analysts
- Buy
- Price target
- 3.00 (+2999900.0%)
2Y 0.0000 (0.00%)
Key statistics
- Enterprise value
- -6.31M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.29
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -17.92M
- Total cash
- 8.09M
- Total debt
- 0
- Return on equity
- -568.85%
- Short % of float
- 10.45%
- 50-day average
- 0.072222
- 200-day average
- 0.139645
Analyst view
Consensus: buy
- Strong buy0
- Buy2
- Hold3
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 15, 2018 | Mar 1, 2018 | -0.60 | -0.42 | +0.18 | +30.00% |
| Mar 5, 2018 | Dec 1, 2017 | -0.71 | -0.73 | -0.02 | -2.82% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 20, 2018 | Roth Capital | init | — | Buy |
| Dec 28, 2016 | Jefferies | down | — | Hold |
| Dec 28, 2016 | Citigroup | down | — | Neutral |
| Sep 16, 2015 | Citigroup | init | — | Buy |
| May 11, 2015 | Citigroup | up | — | Neutral |
| Mar 4, 2013 | Jefferies | init | — | Buy |
About Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- anthera.com
News
AMD and Cerbras Create A New Blueprint For Hardware 
SpaceX Lost $1 Trillion In A Week. So Why Did Bond Investors Rush To Lend It $20 Billion? 
Anthera Pharmaceuticals (OTCMKTS:ANTH) Shares Cross Above Two Hundred Day Moving Average – What’s Next? 
Anthera Pharmaceuticals (OTCMKTS:ANTH) Stock Passes Above Two Hundred Day Moving Average – What’s Next? 
Anthera Pharmaceuticals (OTCMKTS:ANTH) Shares Cross Above Two Hundred Day Moving Average – What’s Next? 
AM Best Assigns Issue Credit Ratings to Anthem, Inc.'s New Senior Unsecured Notes 
AM Best Comments on Credit Ratings of Anthem, Inc. and Its Subsidiaries Following MMM Holdings, LLC Acquisition Announcement 
Stocks That Hit 52-Week Lows On Tuesday 
Stocks That Hit 52-Week Highs On Tuesday 
Stocks That Hit 52-Week Lows On Friday
Your note
Sign in to keep a note on ANTH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| OLSON CHARLES V | Chief Technology Officer | Stock Award(Grant) | Jan 10, 2017 | 17,519 |
| THOMPSON JOHN CRAIG | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 6, 2017 | 17,590 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wedbush Securities Inc | 0.81% | 210,914 | 25.31K | Jun 29, 2018 |
| CALPERS (California-Public Employees Retirement System) | 0.05% | 12,765 | 1.53K | Jun 29, 2018 |
| Meeder Asset Management, Inc. | 0.03% | 9,035 | 1.08K | Jun 29, 2018 |
| Ladenburg Thalmann Financial Services Inc. | 0.01% | 1,500 | 179 | Jun 29, 2018 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.06% | 276,716 | 439.98K | Dec 30, 2017 |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 0.10% | 27,078 | 43.05K | Dec 30, 2017 |
| Invesco ETF Tr-Invesco Wilshire Micro Cap ETF | 0.02% | 4,710 | 565 | Jun 29, 2018 |
| Vanguard Balanced Index Fund | 0.01% | 3,900 | 6.20K | Dec 30, 2017 |
| Meeder Funds-Spectrum Fund | 0.01% | 2,983 | 4.74K | Dec 30, 2017 |